Background: Age-related hearing and vision problems are common among people
Introduction
In the near future, the number of people with dementia is likely to rise significantly across the globe, so improved treatment and care for people with dementia has been identified as an international priority (Alzheimer's Disease International, 2016). Nonpharmacological interventions can be effective in improving quality of life, reducing behavioural and psychological symptoms of dementia and reducing the burden on caregivers (Cooper et al., 2012; Douglas et al., 2004) . Such interventions that address hearing and vision impairment among people with dementia are of particular interest due to: the high prevalence of acquired hearing and vision impairment among people with dementia; the negative impact of sensory impairment on dementia-related outcomes for the individual and their care partner; the ease of detection of sensory impairments; the effectiveness of interventions in reducing hearing/vision disability; the low cost and the ready availability of interventions for sensory impairment; and the potential health economic benefits of intervening.
Surveys indicate very high levels of hearing and vision impairment among people with cognitive impairment. In a 2003 UK study (Allen et al.) , 87% of communitydwelling adults with mild-to-moderate levels of dementia had hearing impairment (pure tone thresholds >40dB HL). A recent national survey of vision impairment among adults with dementia aged 60-89 years in the UK estimated that 32.5% had presenting visual acuity worse than 6/12 (Bowen et al., 2016) . Among those living in residential care, 51.4% had visual acuity worse than 6/12. Surveys also indicate that both hearing and vision impairments go undetected and untreated. Hearing impairment was undetected and untreated in 80% of people with dementia living in the community (Allen et al., 2003) and in 50% of people living in a residential home (Cohen-Mansfield and Taylor, 2004) . In the UK, 14% of people with dementia were using outdated refractive prescriptions and 48% of post-refraction visual impairment among people with dementia was due to cataracts, a treatable cause of vision impairment (Bowen et al., 2016) . In spite of this, it is feasible to reliably identify hearing and vision impairments in the majority of people with dementia (Morse et al., 2004; Uhlmann et al., 1989) . Treatments for sensory impairment are effective in improving function and quality of life in adults with unimpaired cognition (Brenner et al., 1993; Chisolm et al., 2007) , and are relatively low in cost (Chao and Chen, 2008; Lansingh et al., 2007; Vitale et al., 2006) , particularly compared to the costs associated with dementia care (Alzheimer's Society, 2015) .
Hearing and vision impairment in elderly people is often associated with negative outcomes, including difficulties in performing activities of daily living, lower quality of life, reduced physical and social activity, increased stress and burden on friends and family, reduced mental well-being (Horowitz, 2004; Strawbridge et al., 2000) and auditory and visual hallucinations (Sanchez et al., 2011; Teunisse et al., 1996) .
Sensory impairments may exacerbate existing problems due to cognitive impairment, thereby reducing quality of life and functional ability while increasing caregiver burden and the likelihood of institutionalisation (Heyl and Wahl, 2012; Palmer et al., 1998) .
The objective of this scoping review was to synthesise the evidence base regarding the effect of treatment of hearing and vision impairment in people living with dementia on the following outcomes: (i) cognition; (ii) rate of cognitive decline; (iii) behavioural and psychological symptoms of dementia; (iv) hearing or vision-related quality of life; (v) general quality of life; (vi) activities of daily living; and (vii) caregiver burden for adults with dementing conditions. Due to the small evidence base, studies using a range of designs were included.
Methods
The protocol for this study was listed with the PROSPERO international register of systematic reviews (registration number 2016:CRD42016039737). Due to the lack of randomised controlled trials in this area, scoping review methodology was selected as the most appropriate means of analysis. Scoping reviews encompass various study designs and broader subject material than systematic reviews (Arksey and O'Malley, 2005) . They do not focus on study quality, but instead explore the breadth and depth of the existing research to identify areas requiring further investigation (Davis et al., 2009) . Acquisition, extraction, assessment and reporting of the data in the present review was carried out according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) Statement (Moher et al., 2009) .
Eligibility criteria
Studies were eligible for inclusion if they included adult participants who were: (i) resident in community or institutional settings; (ii) aged over 50 years (to differentiate from atypical young onset dementia) and (iii) diagnosed with a progressive neurodegenerative condition leading to dementia, including 'mild cognitive impairment' (MCI; defined according to Petersen criteria; Petersen, 2011) (ii) assistive devices (including corrective refraction, talking barcode scanners, colour helpers); (iii) environmental modifications (including room lighting); or (iv) vision tactics (including problem solving training, behavioural training, resource activation or mobility training).
Randomised controlled trials, quasi-experimental studies and observational studies were included. For those studies with comparison conditions, the comparison could have included placebo/sham, standard care, alternative intervention or no intervention. Process evaluation studies that did not include outcomes of the intervention were excluded due to the focus of the review being on the outcomes of sensory interventions for people with dementia, rather than the development, implementation or delivery of sensory interventions. Zarit et al.,1985) .
Adverse effects or complications of interest included non-adherence or nonacceptance of interventions, including non-use of assistive devices.
Studies were included if published in any official language of the European Union, with no restriction on publication date. Both peer reviewed studies and articles from the grey literature were included. Editorials, newspaper articles and other forms of popular media were excluded. Studies were not selected on the basis of methodological quality.
Data sources
The search strategy included: (i) computer searches of electronic databased; (ii) consultation with an expert network; and (iii) hand-searching the reference lists of eligible papers for additional studies. To ensure that all available relevant studies were captured in our review, w undertook an international consultation with 53 clinical and/or academic experts in the fields of psychiatry, geriatric medicine, psychology, neurology, audiology/otolaryngology and optometry/ophthalmology in the US, the UK, France, Greece, Cyprus, Germany, Norway, the Netherlands and Demark. The experts were contacted via email and asked whether they were aware of any relevant published, unpublished or on-going studies that were not identified on the basis of the computer search. Four professionals offered additional suggestions. Finally, hand searching of the reference lists of all papers eligible for inclusion in the review was carried out to identify further studies of interest.
Study selection
Step 1: Study titles were independently reviewed by the authors and selected for further review if the title included mention of evaluation of intervention or management of hearing or vision impairment in adults with cognitive impairment (including dementia or mild cognitive impairment).
Step 2: Abstracts were independently reviewed by the first and second authors (PD and LW) and selected for further review based on the same criteria as step 1. If a consensus was not reached, the full text of the paper was reviewed.
Step 3: Full-text articles of abstracts selected in Step 2 were reviewed by the first and second authors. Disagreements were discussed with additional authors. Full-text articles were reviewed according to the eligibility criteria described above. The study selection process and reasons for exclusion were recorded (Figure 1 ).
(insert Figure 1) 
Data extraction and analysis
Data extraction was based on the parameters listed in table 1, including participant details, intervention type, and outcome measure. Data were extracted from the fulltext article by reviewer PD and reviewed by a second reviewer (LW). Disagreements were recorded and resolved by involvement of an additional reviewer.
Results were summarised descriptively according to whether there was a reported improvement, deterioration, or no change in each respective outcome measure.
Where the necessary statistics were reported, effect sizes (Cohen's d) for statistically significant changes were calculated with a view to summarise the effects of hearing/vision intervention for each outcome variable if sufficient data on effect sizes were available. Heterogeneity of study design and outcomes of interest, use of informal outcome measures and lack of reporting of the required statistics precluded statistical synthesis of results across studies.
Study design was described according to the Oxford 2011 Levels of Evidence
(OCEBM Levels of Evidence Working Group, 2011, which are: Level 1, fully powered randomised controlled trials or meta-analysis; Level 2, controlled trials without randomisation; Level 3, retrospective cohort or case-control studies; Level 4, case series or uncontrolled single group study; and Level 5, expert opinion or case report).
Risk of bias was assessed using Downs & Black's (1998) checklist for assessing the quality of randomised and non-randomised studies. The checklist contains 27 items pertaining to the quality of reporting, internal and external validity and statistical power with a maximum possible score of 30. Data concerning the development, piloting and evaluation of the sensory interventions were extracted and described according to the Criteria for Reporting the Development and Evaluation of Complex Interventions in healthcare: revised guideline (CReDECI 2) (Möhler et al., 2015) .
Study quality ratings were carried out independently by reviewers PD and LW. Any disagreements were recorded and resolved by involvement of an additional reviewer.
Results

Vision
Five studies that reported vision interventions for people with dementia were identified ( Table 1) . Three studies reported on cataract surgery intervention, one on vision rehabilitation training, and one on prism lenses. One study used a prospective controlled design. The remaining studies were case reports or single group intervention studies. All studies were of low to moderate quality; all scored ≤15 on Downs & Black's (1998) checklist for assessing the quality of randomised and nonrandomised studies. Low quality scores were due to limitations in the quality of reporting, internal validity (bias and confounding), power, and external validity. In relation to the quality of reporting of the intervention according to CReDECI 2 criteria (Table 2) , three studies included a theoretical rationale for the intervention (item 1) (Girard et al., 2016; Lerner et al., 2014; Whitson et al., 2013) and two studies reported rationale for specific elements of the intervention (Girard et al., 2016; Whitson et al., 2013) . No study reported intended interactions between components (item 3) or consideration of context (item 4). No study reported on feasibility or piloting (item 5). Only two studies reported on elements of evaluation including the strategy for delivering the intervention (item 7), intervention materials (item 8), and fidelity of intervention delivery (item 9) (Girard et al., 2016; Whitson et al., 2013) .
Only Whitson et al (2013) reported a process evaluation (item 10), external factors that impacted on the intervention (item 12) and some evaluation of resources required (item 13). (Insert table 1 Izzo et al. (1986) described the case of a woman with mild dementia following progressive supranuclear palsy prescribed prism lenses. An anecdotal description of improvement in reading ability and vision in the vertical plane was included.
Vision rehabilitation training
Whitson et al. Lerner et al. (2014) reported the results of cataract surgery for patients with dementia compared to a control group with dementia. The control group had either declined cataract surgery or were on a waiting list. The mean Mini-mental State Examination (MMSE; Folstein et al., 1975) score in the intervention group was 18.3, indicating a milder level of cognitive impairment than in the control group which had an average score of 14. All participants had a cataract in one or both eyes. Mean visual acuity in the better eye was LogMAR 0.336 for the intervention and 0.381 for the control group. No significant decline in MMSE score in the intervention group six months after pre-surgery baseline assessment was observed, however, in the nonintervention control group, a decline in cognition was seen (corresponding to -0.54 MMSE points/year in the intervention group and -3.3 points/year in the intervention group). Furthermore, a significant reduction in neuropsychiatric symptoms (assessed with the Neuropsychiatric Inventory; NPI; Cummings et al., 1994) in the intervention group was seen, compared with the control group which had a significant increase in these symptoms (NPI score from ~11 to ~6 in the intervention group versus ~15 to ~19 in the control group. Approximate values are reported from a figure). There was a significant reduction in caregiver distress due to neuropsychiatric symptoms (as per the NPI's 'caregiver distress' scale) in the intervention group (from ~6 to ~3), with no significant change in the level of caregiver distress in the control group (from ~6 to ~7). A range of ophthalmologic adverse events in the intervention group was reported, although it was not clear whether these adverse events were higher than expected. 
Cataract surgery
Hearing
Twelve papers that reported on ten separate studies of hearing interventions for people with dementia were identified (Table 3) . Six studies reported on hearing aid provision, one study on hearing aid 'trouble shooting', one study on provision of assistive listening devices, one study on provision of assistive listening devices plus information on hearing loss and communication training and one study on cochlear implantation interventions. One high quality randomised controlled trial was identified. The remaining studies were case reports, single subject design or pre-post test single group design. As with the studies of vision interventions above, most studies were of low to moderate quality (≤18 on Downs & Black's (1998) checklist for assessing the quality of randomised and non-randomised studies). In relation to the quality of reporting according to CReDECI 2 criteria (Table 4) , all studies included a theoretical rationale (item 1) and most provided a rationale for specific elements of the intervention (item 2). No study reported on pilot or feasibility testing (item 5). Two studies provided a rationale for the control/comparison condition (item 6) (Palmer et al., 1999; Palmer et al., 1998) , and one study provided a description but no rationale for the control condition (Adrait et al., 2017; Nguyen et al., 2017) . Only two studies reported a strategy for the delivery (item 7) (Haque, 2012; Mamo et al., 2017) and six studies included a full or partial description of the intervention materials (item 8) (Adrait et al., 2017; Allen et al., 2003; Hopper et al., 2016; Mamo et al., 2017; Nguyen et al., 2017; Palmer et al., 1999; Palmer et al., 1998) . No study reported on the fidelity of intervention delivery (item 9) and only two studies conducted a partial process evaluation (item 10; with no interpretation in relation to a theoretical basis; Mamo et al., 2017; Palmer et al., 1998) . Only two studies reported on the impact of internal (item 11) (Palmer et al., 1998) and external (item 12) (Haque, 2012; Palmer et al., 1998) Palmer et al. (1998) described the case of a man with moderate dementia (MMSE score 18) with moderate-to-severe sensorineural bilateral hearing loss (mean threshold 64.2dB HL over 250-8,000Hz) who was fitted with a unilateral in-the-ear style hearing aid. An improvement in neuropsychiatric behaviours was seen. The neuropsychiatric assessment was based on informal observations of five problematic behaviours identified by the caregiver using the Behavioral Pathology in Alzheimer's Disease Rating Scale (BEHAVE-AD; Reisberg et al., 1987) questionnaire and with charting of the behaviours using a single-subject continuous assessment ABAB design (the hearing aid worn for three weeks, then withdrawn for repairs for one week and returned for the final six weeks of the study). The frequency of problematic behaviours was continuously assessed throughout. The authors reported a clinically significant reduction in hearing disability based on both patient and caregiver report (Hearing Handicap Inventory), before and after the provision of the hearing aid (improvement of ~25 to ~10 for patient-reported and ~40 to ~0 for spouse-reported Hearing Handicap Inventory scores. Approximate values are reported from a figure).
Palmer et al. followed their single case study with a subsequent report of eight participants with moderate to severe dementia (MMSE range 5-18) with mild to moderate symmetrical bilateral sensorineural hearing impairment (mean threshold 50.7 dB HL over 250-8,000 Hz) (Palmer et al., 1999) . As with the single case study, multiple observations of neuropsychiatric behaviours were made pre-and posthearing aid fitting with a unilateral in-the-ear style hearing aid. A significant reduction in between one to four problematic behaviours was identified by the caregiver for each participant using the BEHAVE-AD questionnaire. Seven out of eight caregivers reported a clinically significant reduction in hearing disability (using the Hearing Handicap Inventory) before and after hearing aid fitting. Allen et al. (2003) reported on a single group intervention involving provision of a unilateral behind-the-ear style hearing aid for people with moderate dementia (mean MMSE score, 18) and pure tone audiometric thresholds greater than 40 dB HL.
Poorer cognitive function between baseline and 24 weeks post-hearing aid fitting was seen (mean MMSE score declined to 16). However, the authors estimated that there was a reduction in the rate of cognitive decline, compared to the estimated rate of cognitive decline for populations with similar severity of cognitive impairment based on MMSE and Euro-Alzheimer's Disease Assessment Scale (Verhey et al., 2004) normative performance. There was no significant change in neuropsychiatric symptoms (using the Manchester and Oxford Universities Scale for the Psychopathological Assessment of Dementia; MOUSEPAD; Allen et al., 1996) .
There was a significant reduction in hearing related disability (using the Nursing Home Hearing Handicap Index for patient and carer; Schow and Nerbonne, 1977) .
There was no significant change in activities of daily living (using the Instrumental Deterioration for Daily Living in Dementia scale (Barberger-Gateau et al., 1992) nor caregiver burden based on NPI Carer burden and Carer strain scales). By the end of the study, 56% of the sample reported using their hearing aids either every day or most days. The authors reported statistically significantly less hearing disability for those who used their hearing aids every day versus those who used hearing aids less often, but no difference on any other outcome measure was seen. Hutchinson et al. (2012a; 2012b) described eight cases of people with dementia and mild-to-severe hearing impairment who were fitted with bilateral behind-the-ear style hearing aids. The severity of dementia was reported in terms of the research audiologist's clinical impression, which ranged from 'no dementia' to 'moderate'.
Eight participants were reported to have completed the study, although data from ten participants were presented in relation to the neuropsychiatric symptoms outcome measure. A reduction in neuropsychiatric symptoms 30 days after hearing aid fitting (based on recording of three problematic behaviours that were identified by the caregiver using a version of the BEHAVE-AD questionnaire, which was incorrectly attributed to Palmer et al. (1998) hearing aids were unilaterally or bilaterally fitted was reported. However, participants received hearing aids with either fast or slow release times. 'Release time' refers to how quickly a hearing aid responds to changes in input levels by decreasing or increasing gain. The advantage of a short release time is that the hearing aid quickly returns to normal levels of gain, although short release times may worsen sound quality. Long release times facilitate sound quality but may result in some signal (e.g. on-going speech) being under-amplified, with adverse impact on speech recognition.
The study found a significant reduction in hearing disability (HHIE) compared to baseline, 4 months after hearing aid fitting. There were no differences between fast/slow release time subgroups (improvement of 70% to 25% for the fast subgroup and 71% to 26% for the slow release time subgroup in HHIE scores). Rabins et al., 1999) were completed at baseline, six months and 12 months. Hearing aid use was high (83.3% of active and 62.3% placebo wore their hearing aids for more than five hours per day). Hearing aid use was more consistent among younger patients, but was not related to cognitive status or severity of hearing impairment. No adverse events related to hearing aids were recorded. Scores on all outcome measures worsened over time. There were no statistically significant differences in any outcome measure between the active and placebo group at six months, or before and after hearing aid activation in the placebo group. There was a statistically non-significant trend for lower decline in ADAS-cog and statistically significant improvement in Alzheimers Disease-Related Quality of Life scores for those with high hearing aid use versus low users in the active group.
Assistive listening devices
Hopper et al. (2016) The intervention was delivered to participants who were resident in the community and attending a memory clinic (mean MMSE score = 19.2; mean hearing threshold 48.2 dB HL). Behavioral and psychological symptoms of dementia and caregiver burden were assessed at baseline and one month post intervention. Assistive listening devices were well accepted and used at least some of the time by 74% of participants, and caregivers reported subjective improvements in engagement and communication. But there was no statistically significant change in behavioural and psychological symptoms of dementia (carer-completed NPI) or caregiver burden (Zarit Burden Interview) . Measures of hearing disability were carried out post intervention only and were not analysed statistically. Modest et al. (2015) included a description of the case of a 70-year-old woman with dementia in the mild stage associated with superficial siderosis. Pure tone audiometric thresholds indicated moderate/severe hearing loss in the left ear and profound hearing loss in the right ear. The woman was given a unilateral cochlear implant. There was an immediate subjective improvement in hearing following implantation, however the woman reported no sustained benefit from implantation at follow-up 18 months after implantation. It was observed that the women had experienced significant progression in severity of dementia over the 18 month followup period that may have offset the gains provided by the cochlear implant.
Cochlear implants
Discussion
The review identified 17 papers that reported the impact of treating hearing or vision impairment in people with dementia. Studies generally reported improvements in outcome measures post intervention. The present review included grey literature, and inclusion of grey literature may reduce reporting bias (Moher et al., 2009) . But it may be that negative outcomes from interventions remain unreported, reflecting a marked reporting bias that is a limitation in our ability to synthesise the evidence.
Addressing sensory impairment has promise as a non-pharmacological option for improving outcomes for people with dementia, although there is a clear need to improve the quality of research. Only one high quality randomised controlled trail was reported (Adrait et al., 2017; Nguyen et al., 2017) and only one other study (Lerner et al., 2014 ) included a control group. All remaining studies were of low-tomoderate quality, and consisted of low-level evidence, such as single case reports, small case series or uncontrolled and underpowered treatment trials. Only five papers (Adrait et al., 2017; Hopper et al., 2016; Mamo et al., 2017; Nguyen et al., 2017; Whitson et al., 2013) The most commonly included outcome measures were hearing/vision-related disability and behavioural and psychological symptoms of dementia. Addressing sensory impairments may have additional benefits in other areas (e.g. in relation to cognition, quality of life, functional abilities and caregiver burden) although these outcomes were not consistently included across studies. Studies included adults with a range of levels of severity of dementia. However, some studies either did not report the severity of dementia or did not describe the criteria for establishing severity. The subtype of dementia was either described as Alzheimer disease (or superficial siderosis by Modest et al. 2015) or was not reported. The effectiveness of sensory interventions may differ according to severity of dementia and dementia subtype, and so it is problematic that no study reported the outcomes of sensory interventions according to dementia severity or dementia subtype. Analysis of outcomes by severity/subtype was not possible in the present review due to the small numbers of studies in the review and the limitations of reporting.
Hearing interventions
Hearing interventions mostly involved provision of a hearing aid, with five studies reporting on provision of a hearing aid (Adrait et al., 2017; Allen et al., 2003; Ghiringhelli and Iorio, 2013; Hutchinson et al., 2012; Hutchison et al., 2012; Nguyen et al., 2017; Palmer et al., 1999; Palmer et al., 1998) , and one additional study studies, levels of hearing impairment were not reported. However, reassuringly, the diagnosis of hearing impairment was based on audiometric assessment in all the studies reported. Furthermore, all the reported studies of hearing aid interventions found good compliance with hearing aid use across a range of severities of dementia and which were comparable to levels of use reported among non-cognitively impaired new hearing aid users (Aazh et al., 2015) . Palmer et al. (1999; reported selecting a harder to remove in-the-ear style hearing aid rather than a behind-the-ear style aid. However, hearing aid use was reported to be similarly high in studies that reported using behind-the-ear style aids. Allen et al. (2003) , Nguyen et al. (2017) and Adrait et al. (2017) reported a tendency for greater improvement in hearing disability, general quality of life and cognition among those who used hearing aids more often compared to those who used them less frequently.
Inconsistent or low hearing aid use may reduce the likelihood of detecting any benefit of hearing aids. Studies of non-surgical interventions for sensory impairment should be powered to take non-adherence into account.
Two studies (Hopper et al., 2016; Mamo et al., 2017) reported on provision of an assistive listening device. Assistive listening devices may have advantages over hearing aids in terms of lower cost (US$3,000-5,000 versus $100-350), accessibility (assistive listening devices may be bought over the counter) and ease of fitting (assistive listening devices do not require fitting by an audiologist). Hopper et al.'s (2016) and Mamo et al.'s (2017) Nguyen et al. (2017) , Adrait et al. (2017) and Allen et al.'s (2003) studies were the only studies that reported outcomes related to cognitive function, activities of daily living and caregiver burden. However, none of these studies reported any benefit of hearing aids in relation to these outcomes. Mamo et al. (2017) also reported no reduction in caregiver burden with use of assistive listening devices. Allen et al. (2003) reported some benefit in relation to cognitive decline, but the single group design used in Allen et al.'s (2003) study made it difficult to disentangle any benefit of the intervention from the natural progression of dementia. No impact of hearing aids on cognitive decline was reported in Nguyen et al. (2017) and Adrait et al.'s (2017) more robustly designed randomised controlled study. Four out of six studies of hearing interventions that assessed behavioural and psychological symptoms of dementia reported an improvement (Ghiringhelli and Iorio, 2013; Hutchinson et al., 2012; Hutchison et al., 2012; Palmer et al., 1999; Palmer et al., 1998) . However, Nguyen et al. (2017) and Adrait et al.'s (2017) randomised controlled trial reported no impact of hearing aids on behavioural and psychological symptoms. The difference in results between Nguyen et al. (2017) and Adrait et al.'s (2017) studies and previous studies may be due to the lack of a control group in the latter. All five studies that assessed hearing disability reported immediate improvement following intervention (Allen et al., 2003; Ghiringhelli and Iorio, 2013; Modest et al., 2015; Palmer et al., 1999; Palmer et al., 1998) .
Finally, only one study described cochlear implantation in a case study of someone with severe hearing impairment and dementia (Modest et al., 2015) . This study reported immediate benefit from the cochlear implant, but no sustained benefit due to progression of dementia (although the patient may presumably have been worse off without the implant). At minimum, this case study provides some evidence that cochlear implantation is feasible for people with dementia and that people with dementia may benefit from cochlear implantation. Two studies reported that cataract surgery was feasible and beneficial for people with dementia (Girard et al., 2016; Lerner et al., 2014) . Surgical cochlear implantation may be a similar case to cataract surgery.
Vision interventions
Three studies reported on the impact of cataract surgery intervention (Girard et al., 2016; Lerner et al., 2014; Payal et al., 2016) , one on rehabilitation training (Whitson et al., 2013) and one on use of prism lenses (Izzo et al., 1986) . There was limited and inconsistent evidence for the benefit of any vision intervention on any outcome measure. Out of two studies that reported on behavioural and psychological outcomes following cataract surgery, Lerner et al. (2014) reported a reduction in behavioural and psychological symptoms of dementia, while Girard et al. (2016) reported an improvement in sleep problems but an increase in agitation, with no change in total symptoms overall. A recent study reported that cataract was the primary cause of post-refraction vision impairment for 48% of people with dementia in the UK, while age-related macular degeneration was the primary cause for 36% (Bowen et al., 2016) . Vision impairment was correctable with refraction for 7-14% of people with dementia (depending on the level of presenting visual acuity). A continued focus on cataract surgery therefore seems indicated. In addition, it would be useful to include studies of the benefits of refractive correction and treatment and management of macular degeneration for people with dementia.
Recommendations for future research
Given the high prevalence and impact of hearing and vision impairments among people with dementia, there is a need for good quality evidence to inform clinical practice and national policy for dementia care in relation to the diagnosis and management of hearing and vision impairment. There is an urgent need for wellcontrolled intervention studies which include measures of hearing/vision disability, behavioural and psychological symptoms of dementia, cognitive function and rate of decline, quality of life, activities of daily living and caregiver burden. Given the complex nature of combined sensory and cognitive impairment and the likely substantial individual differences in the impact of impairment, as well as the need and the preference for particular types of intervention, it would be desirable to develop complex interventions that could be tailored to individual patterns of impairment and patient preference (Craig et al., 2008) . Patient and public input in development of such interventions would likely increase the acceptability and utility of the intervention (Carman et al., 2013) . Including health economic measures to test the cost effectiveness of interventions would increase the relevance and impact of the research in relation to service provision. One example of an ongoing effort to address these issues is the European SENSE-Cog project (www.sense-cog.eu), which is fully-powered randomised controlled trial of a complex support intervention for hearing and vision impairment in people with dementia and concurrent hearing and/or vision impairment (Regan et al., under review) . The trial, which is taking place in five countries, will assess efficacy on a range of dementia-related outcomes (i.e. quality of life, caregiver burden, neuropsychiatric symptoms), as well as costeffectiveness. The intervention was carefully developed according to guidance for the development of complex psychosocial interventions (Leroi et al., 2017) and has been field trialled for feasibility and acceptability (Regan et al., 2017) .
Summary
The 17 studies identified in this review provide some evidence that hearing and vision-enhancing interventions for people with dementia are feasible and may provide benefit, particularly in relation to improving hearing/vision disability and reducing behavioural and psychological symptoms of dementia. There is limited evidence for sensory interventions in relation to cognitive function, rate of cognitive decline, quality of life, activities of daily living, or caregiver burden. Sensory impairments are very common in people with dementia and exacerbate disability and burden on carers. Sensory impairments are easily identifiable, and relatively low-cost effective interventions are readily available. Actively identifying and treating sensory impairments among people with dementia may be an easy, effective and costefficient method of improving quality of life for people with dementia and their caregivers and reducing health care costs for people with dementia. Future research should include better quality reporting, consistent use of an inclusive range of relevant outcomes and more robust study designs to establish the benefit of sensory interventions to improve outcomes for people with dementia.
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